February 15, 2016
Today's bioanalytical (BA) scientists find themselves under a deluge of data. It's no bad thing as this valuable asset is driving research and development (R&D) forward, but it's only useful if that information is stored and curated consistently.
July 21, 2015
As outsourcing becomes more prevalent across scientific domains, and in the bioanalysis sphere in particular, the importance of effective collaboration tools has come to the forefront. More and more companies are turning to external providers to help cut costs and increase speed to market. But what happens to the data when firms enter these types of arrangements?
July 15, 2015
For many scientific operations, day-to-day processes revolve around running assays, getting results and verifying that everything was completed according to the protocol. The challenge inherent in this has been the retrospective approach to quality control (QC). Today’s forward-thinking bioanalytical (BA) laboratories are starting to shift away from this mentality, looking at how they can embed quality into everything they do.
August 19, 2013
The first ever comprehensive guide to experimental methodology for LC-MC bioanalysis (BA) is due to be published shortly. Edited by experts from Novartis Institutes for Biomedical Research, the Handbook of LC-MS Bioanalysis* is the result of an impressive collaboration from across a wide spectrum of the BA community spanning global pharma, regulators including the FDA and technology vendors. The Handbook looks likely to become the authoritative source on scientific, regulatory, quality and technology levers within the BA space.
August 1, 2013
Since the Leahy-Smith America Invents Act (AIA) was passed by Congress and was signed into law by President Obama in September 2011, the clock has been ticking on the current ‘First-to-Invent’ system. This will be a major change for US scientists, especially those working across the spectrum of research and development (R&D).